Citation Impact
Citing Papers
Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
2009
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
2004 Standout
A Designed Angiopoietin-1 Variant, Dimeric CMP-Ang1 Activates Tie2 and Stimulates Angiogenesis and Vascular Stabilization in N-glycan Dependent Manner
2015
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
2014 Standout
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
2014 StandoutNobel
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Axon Guidance Molecules in Vascular Patterning
2010
The angiopoietin:Tie 2 interaction: A potential target for future therapies in human vascular disease
2013
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Advances in metal-induced oxidative stress and human disease
2011 Standout
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
2005
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy
2005
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell–cell and cell–matrix contacts
2008
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Molecular lymphangiogenesis: new players
2005
The Thrombospondins
2011 Standout
Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart
2003
BMPR2 is required for postimplantation uterine function and pregnancy maintenance
2013
Rosiglitazone ameliorates cisplatin-induced renal injury in mice
2006
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
2006
Rac-dependent trans-endocytosis of ephrinBs regulates Eph–ephrin contact repulsion
2003
Angiogenesis and autosomal dominant polycystic kidney disease
2012
Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: Soluble Tie-2
2008
Lymphangiogenesis in development and human disease
2005 StandoutNature
A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis
2009
Bench-to-bedside review: Angiopoietin signalling in critical illness – a future target?
2009
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
2010 Nature
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Development of the retinal vasculature
2007
Vascular endothelial growth factor in eye disease
2008 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
2009
Resveratrol Suppresses Tumor Necrosis Factor-α-Induced Fractalkine Expression in Endothelial Cells
2006
Molecular regulation of angiogenesis and lymphangiogenesis
2007 Standout
A hypoxic inducible factor‐1α hybrid enhances collateral development and reduces vascular leakage in diabetic rats
2009
Endothelial Cell Gene Regulation
2005
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
2010 StandoutNobel
The hallmarks of cancer
2012 Standout
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
2010 Standout
Therapeutic targeting of the angiopoietin–TIE pathway
2017
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Targeting the ANGPT–TIE2 pathway in malignancy
2010
Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
2017 Standout
Impact of oxidative stress on lung diseases
2008
Suppression of angiogenesis by the plant alkaloid, sanguinarine
2004
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
2009
A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor
2004
Hypoxia-Inducible Factor-Dependent Expression of Angiopoietin-Like 4 by Conjunctival Epithelial Cells Promotes the Angiogenic Phenotype of Pterygia.
2017 StandoutNobel
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Tumour stem cells and drug resistance
2005 Standout
In Vivo Actions of Angiopoietins on Quiescent and Remodeling Blood and Lymphatic Vessels in Mouse Airways and Skin
2006
Angiopoietin-3 Inhibits Pulmonary Metastasis by Inhibiting Tumor Angiogenesis
2004
Dimerization of Tie2 mediated by its membrane-proximal FNIII domains
2017
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures
2009
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2
2005
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma
2016 StandoutNobel
`Eph'ective signaling: forward, reverse and crosstalk
2003
F‐domain valency determines outcome of signaling through the angiopoietin pathway
2021 StandoutNobel
Molecular distinction between arteries and veins
2003
Loss of Endothelial Tie1 Receptor Impairs Lymphatic Vessel Development-Brief Report
2009
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Lymphatic vessels in cancer
2022
Signaling and Functions of Angiopoietin-1 in Vascular Protection
2006
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models
2014 Standout
Mechanisms of Endocytosis
2009 Standout
Cellular and Molecular Regulation of Skeletal Muscle Side Population Cells
2004
Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization
2017
Works of So Young Ahn being referenced
Oligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
2005
Tumor Necrosis Factor-α Induces Fractalkine Expression Preferentially in Arterial Endothelial Cells and Mithramycin A Suppresses TNF-α-Induced Fractalkine Expression
2004
Biological characterization of angiopoietin‐3 and angiopoietin‐4
2004
EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cells
2002